DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,950,024 | +2.6% | 28,013 | -0.7% | 2.83% | +9.7% |
Q2 2023 | $6,773,760 | -6.4% | 28,224 | -1.7% | 2.58% | -10.3% |
Q1 2023 | $7,234,808 | -5.1% | 28,705 | -0.1% | 2.88% | -9.4% |
Q4 2022 | $7,625,517 | +2.0% | 28,730 | -0.7% | 3.18% | -5.0% |
Q3 2022 | $7,476,000 | +0.8% | 28,945 | -1.0% | 3.34% | +8.2% |
Q2 2022 | $7,414,000 | -13.6% | 29,245 | -0.0% | 3.09% | +0.9% |
Q1 2022 | $8,581,000 | -11.1% | 29,250 | -0.3% | 3.06% | -4.9% |
Q4 2021 | $9,653,000 | +4.2% | 29,340 | -3.6% | 3.22% | -5.2% |
Q3 2021 | $9,265,000 | +11.5% | 30,434 | -1.7% | 3.40% | +10.3% |
Q2 2021 | $8,312,000 | +17.8% | 30,971 | -1.2% | 3.08% | +12.0% |
Q1 2021 | $7,057,000 | +2.2% | 31,352 | +0.9% | 2.75% | -2.2% |
Q4 2020 | $6,902,000 | -1.9% | 31,071 | -4.9% | 2.81% | -9.3% |
Q3 2020 | $7,039,000 | +18.7% | 32,682 | -2.6% | 3.10% | +11.9% |
Q2 2020 | $5,932,000 | +27.2% | 33,551 | -0.4% | 2.77% | +7.2% |
Q1 2020 | $4,664,000 | -12.7% | 33,693 | -3.2% | 2.58% | +8.7% |
Q4 2019 | $5,344,000 | +5.0% | 34,815 | -1.2% | 2.38% | -0.6% |
Q3 2019 | $5,089,000 | +0.3% | 35,230 | -0.7% | 2.39% | -0.2% |
Q2 2019 | $5,073,000 | +7.7% | 35,485 | -0.5% | 2.40% | +5.3% |
Q1 2019 | $4,709,000 | +28.7% | 35,665 | +0.5% | 2.27% | +12.8% |
Q4 2018 | $3,659,000 | +5.5% | 35,475 | +11.2% | 2.02% | +8.7% |
Q3 2018 | $3,468,000 | +12.2% | 31,915 | +1.9% | 1.85% | +1.3% |
Q2 2018 | $3,090,000 | +6.1% | 31,315 | +5.3% | 1.83% | +4.9% |
Q1 2018 | $2,911,000 | +9.2% | 29,740 | +3.5% | 1.74% | +13.8% |
Q4 2017 | $2,666,000 | +19.2% | 28,725 | +10.2% | 1.53% | +9.3% |
Q3 2017 | $2,237,000 | +4.6% | 26,075 | +2.9% | 1.40% | +1.3% |
Q2 2017 | $2,139,000 | +3.3% | 25,345 | +4.7% | 1.38% | +1.8% |
Q1 2017 | $2,071,000 | +22.3% | 24,215 | +11.3% | 1.36% | +16.5% |
Q4 2016 | $1,694,000 | +50.0% | 21,760 | +51.1% | 1.17% | +51.2% |
Q3 2016 | $1,129,000 | +9.5% | 14,405 | +41.0% | 0.77% | +6.8% |
Q2 2016 | $1,031,000 | +91.3% | 10,215 | +79.6% | 0.72% | +88.8% |
Q1 2016 | $539,000 | +13375.0% | 5,687 | +13440.5% | 0.38% | +12666.7% |
Q3 2015 | $4,000 | – | 42 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |